Events
09:30 - 13:00
This was 1 year ago
webinar
The Commission gives a webinar tackling the following details of grant management:
A Q&A session with SLIDO is foreseen.
The programme and the link to the You Tube live stream can be found on this link. No prior registration is requested.
You can also go directly to the Commission You tube channel: EU Science & Innovation - YouTube (tab live).
Details about grant preparation will be explained in a webinar by the Commission on 20 March (cfr. our event calendar). On 13 March a webinar on funding opportunities and submitting a proposal is also scheduled (cfr. our event calendar).
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
EIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...
Read moreThis one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.
Read moreThe European Commission’s flagship research and innovation event aims to bring together policymakers, researchers, innovators, business leaders and representatives of civil society. It is designed to look at how research and innovation can strengthen Europe’s competitiveness, resilience and technological sovereignty. The programme is expected to include high-level policy discussions, breakout sessions, networking opportunities, award ceremonies and exchanges with EU Science Counsellors.
Read moreThis event looks at how environmental research contributes to Europe’s competitiveness, resilience, strategic autonomy and security. The programme aims to combine high-level policy reflections, examples of research impact and a discussion on the future direction of European environmental research. It ends with a networking reception marking...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
